Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

EPPOCRATIS: Expedited Preoperative Point-of-Care Reduction of Fractures to Normalized Anatomy and Three-Dimensional Printing to Improve Surgical Outcomes
Sharaf, Basel, Kuruoglu, Doga, Cantwell, Sean R., Alexander, Amy E., Dickens, Hunter J., Morris, Jonathan M., Sharaf, Basel , Sharaf, Basel A , Kuruoglu, Doga, Cantwell, Sean R., Alexander, Amy E., Dickens, Hunter J., Morris, Jonathan M.

Mayo Clinic

Plastic & Reconstructive Surgery | February 23, 2022 | Volume: 149 | Issue: 3 | Pages: 695-699

10.1097/prs.0000000000008871 | PMID 35196689 Get It

Summary: Virtual surgical planning and three-dimensional printing have been invaluable tools in craniomaxillofacial surgery. From planning head and neck reconstruction to orthognathic surgery and secondary reconstruction of maxillofacial trauma, virtual surgical planning and three-dimensional printing allow the surgeon to rehearse the surgical plan and use patient-specific surgical guides for carrying out the plan accurately. However, the process of virtual surgical planning and three-dimensional printing requires time and coordination between the surgeon on one hand and the biomedical engineers and designers on the other hand. Outsourcing to third-party companies contributes to inefficiencies in this process. Advances in surgical planning software and three-dimensional printing technology have enabled the integration of virtual surgical planning and three-dimensional printing at the treating hospital, the point of care. This allows for expedited use of this process in semiurgent surgical cases and acute facial trauma cases by bringing the surgeon, radiologist, biomedical engineers, and designers to the point of care. In this article, the authors present the utility of EPPOCRATIS, expedited preoperative point of care reduction of fractures to normalized anatomy and three-dimensional printing to improve surgical outcomes, in the management of acute facial trauma.
Shoulder Periprosthetic Joint Infection and All-Cause Mortality: A Worrisome Association
Austin, Daniel C., Townsley, Sarah H. , Rogers, Thomas H., Barlow, Jonathan D. , Morrey, Mark E., Sperling, John W. , Sánchez‐Sotelo, Joaquín , Sanchez-Sotelo, J. , Barlow, Jonathan D , Austin, Daniel C., Townsley, Sarah H. , Rogers, Thomas H., Morrey, Mark E., Sperling, John W

Mayo Clinic

JBJS Open Access | February 23, 2022 | Volume: 7 | Issue: 1 | Pages: No page available

10.2106/jbjs.oa.21.00118 | PMID 35224410 Get It

Background: Periprosthetic joint infection (PJI) can be a devastating complication following shoulder arthroplasty. PJI following hip and knee arthroplasties has been found to increase mortality. However, anatomical and bacteriologic differences could potentially result in a different trend after shoulder arthroplasties. Thus, the purpose of the present study was to determine whether there is an association between shoulder PJI and all-cause mortality. Methods: Our institutional Total Joint Registry Database was queried to identify patients who underwent revision shoulder arthroplasty procedures between 2000 and 2018. A total of 1,160 procedures were then classified as either septic (21.8%) or aseptic (78.2%). Septic revisions were further subdivided into (1) debridement, antibiotics, irrigation, and implant retention (9.1%); (2) 2-stage reimplantation for deep infection (61.3%); (3) implant resection without reimplantation (3.6%); and (4) unexpected positive cultures at revision surgery (26.1%). The most common bacterium isolated was Cutibacterium acnes (64.4%). All-cause patient mortality was determined with use of our registry and confirmed with use of a nationwide mortality database. All-cause crude and adjusted mortality rates were then compared between groups. Results: The 1-year crude mortality rate was 1.8% (95% confidence interval [CI], 0.9% to 2.6%) for the aseptic group and 2.8% (95% CI, 0.7% to 4.8%) for the septic group (p = 0.31). Multivariate Cox regression analysis demonstrated an elevated but statistically similar adjusted hazard ratio for 1-year all-cause mortality of 1.9 (95% CI, 0.8 to 4.6) when comparing the septic to the aseptic group (p = 0.17). The risk of 2-year all-cause mortality was significantly higher in the septic group, with a hazard ratio of 2.2 (95% CI, 1.1 to 4.5; p = 0.029). In univariate analyses, increased 5-year mortality in the septic revision group was associated with age, Charlson Comorbidity Index, and methicillin-resistant Staphylococcus aureus infection, whereas C. acnes infection was associated with lower mortality. Conclusions: Shoulder PJI is associated with an adjusted 2-year all-cause mortality rate that is double that of aseptic patients. The results of the present study should be utilized to appropriately counsel patients who are considered to be at risk for infection following shoulder arthroplasty. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
Randomized Trial of a Web-Based Tobacco Treatment and Online Community Support for People With HIV Attempting to Quit Smoking Cigarettes
Shuter, Jonathan, Chander, Geetanjali, Graham, Amanda L., Kim, Ryung S., Stanton, Cassandra A., Shuter, Jonathan, Chander, Geetanjali, Graham, Amanda L., Kim, Ryung S., Stanton, Cassandra A.

Mayo Clinic

JAIDS Journal of Acquired Immune Deficiency Syndromes | February 17, 2022 | Volume: 90 | Issue: 2 | Pages: 223-231

10.1097/qai.0000000000002936 | PMID 35175971 Get It

Background: Persons with HIV (PWH) in the United States (US) smoke cigarettes at approximately triple the rate of the general adult population and are less successful in their quit attempts than other smokers. This randomized trial tested whether a novel web-based cessation program for PWH yielded higher cigarette quit rates compared with a control program. Setting: Two urban HIV care sites in NYC and Baltimore. Methods: Between 2016 and 2020, 506 PWH were randomized to either Positively Smoke Free on the Web (PSFW+; N = 255), a multimodal platform, interactive web intervention hosted within an online social network to support quitting among PWH who smoke, and an attention-matched web-based control intervention (American Heart Association Getting Healthy; N = 251). All participants were offered 12 weeks of nicotine patch. Our primary outcome was biochemically confirmed exhaled carbon monoxide < 10 parts per million (ppm) 7-day point prevalence abstinence at 6 months. Results: Participants were middle-aged (mean 50.2 years; range 23–73 years), 57% male, 19% Latinx, 83% Black, and 13% White. At 6 months, a significantly greater percentage of PSFW+ participants (14.9%) achieved biochemically confirmed 7-day point prevalence abstinence in intent-to-treat analysis compared with 8.8% of American Heart Association Getting Healthy participants [odds ratio =1.82 (95% confidence interval =1.04 to 3.18), P = 0.03]. Conclusions: PSFW+ is a promising cessation intervention composed of empirically tested content and real-time social support through an online social network that was found to promote abstinence. This digital approach has broad reach and scalability, can be easily integrated into comprehensive HIV care, and represents an advance in the fight against tobacco use among PWH.
Chaput tubercle avulsion: Sonographic appearance and diagnosis
Shrestha, Roman , Dahiya, Nirvikar , Alli, Adebisi , Long, Jeremiah R. , Flug, Jonathan A.

Mayo Clinic

PM&R | February 15, 2022 | Volume: 14 | Issue: 4 | Pages: 515-517

10.1002/pmrj.12786 | PMID 35166039 Get It

Comparative Effectiveness of Landmark-guided Greater Occipital Nerve (GON) Block at the Superior Nuchal Line Versus Ultrasound-guided GON Block at the Level of C2
Kissoon, Narayan R., O’Brien, Travis G., Bendel, Markus A., Eldrige, Jason S., Hagedorn, Jonathan M., Mauck, William D., Moeschler, Susan M., Olatoye, Oludare O., Pittelkow, Thomas P., Watson, James C., Pingree, Matthew J., Kissoon, Narayan R., O’Brien, Travis G., Bendel, Markus A., Eldrige, Jason S., Hagedorn, Jonathan M., Mauck, William D., Moeschler, Susan M., Olatoye, Oludare O., Pittelkow, Thomas P., Watson, James C., Pingree, Matthew J.

Mayo Clinic

The Clinical Journal of Pain | February 8, 2022 | Volume: 38 | Issue: 4 | Pages: 271-278

10.1097/ajp.0000000000001023 | PMID 35132029 Get It

Objectives: The purpose of this single center, prospective randomized controlled trial was to compare clinical outcomes between an ultrasound-guided greater occipital nerve block (GONB) at the C2 vertebral level versus landmark-based GONB at the superior nuchal line. Methods: Patients with occipital neuralgia or cervicogenic headache were randomized to receive either a landmark-based GONB with sham ultrasound at the superior nuchal line or ultrasound-guided GONB at the C2 vertebral level with blinding of patients and data analysis investigators. Clinical outcomes were assessed at 30 minutes, 2 weeks, and 4 weeks postinjection. Results: Thirty-two patients were recruited with 16 participants in each group. Despite randomization, the ultrasound-guided GONB group reported higher numeric rating scale (NRS) scores at baseline. Those in the ultrasound-guided GONB group had a significant decrease in NRS from baseline compared with the landmark-based GONB group at 30 minutes (change of NRS of 4.0 vs. 2.0) and 4-week time points (change of NRS of 2.5 vs. −0.5). Both groups were found to have significant decreases in Headache Impact Test-6. The ultrasound-guided GONB had significant improvements in NRS, severe headache days, and analgesic use at 4 weeks when compared with baseline. No serious adverse events occurred in either group. Conclusions: Ultrasound-guided GONBs may provide superior pain reduction at 4 weeks when compared with landmark-based GONBs for patients with occipital neuralgia or cervicogenic headache.
Adverse Events Associated With 10-kHz Dorsal Column Spinal Cord Stimulation
D’Souza, Ryan S. , Olatoye, Oludare, Butler, Casey S. , Ashmore, Zachary , Ashmore, Zachary M, D'Souza, Ryan S , Barman, Ross , Hagedorn, Jonathan M.

Mayo Clinic

The Clinical Journal of Pain | February 8, 2022 | Volume: 38 | Issue: 5 | Pages: 320-327

10.1097/ajp.0000000000001026 | PMID 35132023 Get It

Background: High-frequency (10-kHz) spinal cord stimulation (SCS) continues to be an emerging therapy in chronic pain management. The same complications that plagued earlier SCS systems may affect newer stimulation technologies, although there is limited data on the type of complications and surgical management of these complications. Objective: The aim of this study was to systematically examine real-world complications associated with 10-kHz SCS reported on the Manufacturer and User Facility Device Experience (MAUDE) database. Materials and Methods: The MAUDE database was queried for entries reported between January 1, 2016 and December 31, 2020. Entries were classified into procedural complications, device-related complications, patient complaints, surgically managed complications, serious adverse events, and/or other complications. Primary outcomes included type and frequency of complications, and surgical management of complications. Results: A total of 1651 entries were analyzed. Most entries were categorized as procedural complications (72.6%), followed by serious adverse events (10.5%), device-related complications (10.5%), and patient complaints (9.9%). Most complications were managed surgically with explant (50.9%) rather than revision (5.0%) or incision/drainage (6.6%). Of procedural complications, the most common entries included non-neuraxial infection (52.9%), new neurological symptoms (14.7%), and dural puncture (9.5%). Of device-related complications, the most common entries included lead damage (41.6%), erosion (18.5%), and difficult insertion (11.5%). Conclusion: This retrospective 5-year analysis of complications from10-kHz SCS provides a real-world assessment of safety data unique for this stimulation modality. This analysis may help inform future clinical decisions, lead to device enhancement and optimization, and improve mitigation of risks to provide safe and efficacious use of 10-kHz SCS.
Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Far Lateral Approach
Graffeo, Christopher S. , Perry, Avital , Carlstrom, Lucas P. , Leonel, Luciano, Nguyen, Bachtri T. , Driscoll, Colin L. W., Link, Michael J. , Peris-Celda, Maria, Leonel, Luciano César Pereira Campos , Nguyen, Bachtri , Morris, Jonathan M. , Peris‐Celda, Maria

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 4, 2022 | Volume: 84 | Issue: 02 | Pages: 170-182

10.1055/a-1760-2528 | PMID 36895809 Get It

Abstract Introduction Skull base neuroanatomy is classically taught using surgical atlases. Although these texts are critical and rich resources for learning three-dimensional (3D) relationships between key structures, we believe they could be optimized and complemented with step-by-step anatomical dissections to fully meet the learning needs of trainees. Methods Six sides of three formalin-fixed latex-injected specimens were dissected under microscopic magnification. A far lateral craniotomy was performed by each of three neurosurgery resident/fellow at varying stages of training. The study objective was the completion and photodocumentation of the craniotomy to accompany a stepwise description of the exposure to provide a comprehensive, intelligible, and anatomically oriented resource for trainees at any level. Illustrative case examples were prepared to supplement approach dissections. Results The far lateral approach provides a wide and versatile corridor for posterior fossa operation, with access spanning the entire cerebellopontine angle (CPA), foramen magnum, and upper cervical region. Key Steps Include The study includes the following steps: positioning and skin incision, myocutaneous flap, placement of burr holes and sigmoid trough, fashioning of the craniotomy bone flap, bilateral C1 laminectomy, occipital condyle/jugular tubercle drilling, and dural opening. Conclusion Although more cumbersome than the retrosigmoid approach, a far lateral craniotomy offers unparalleled access to lesions centered lower or more medially in the CPA, as well as those with significant extension into the clival or foramen magnum regions. Dissection-based neuroanatomic guides to operative approaches provide a unique and rich resource for trainees to comprehend, prepare for, practice, and perform complex cranial operations, such as the far lateral craniotomy.
Multi‐institutional review of non‐hypospadiac penile urethral stricture management and outcomes
Abramowitz, David , Sam, Andre‐Philippe , Pachorek, Mark, Martins, Francisco E. , Angulo, J.C. , Simhan, Jay , Li, Eric , Policastro, Connor, Ramírez-Pérez, E. A. , Burks, Frank , Shetty, Zubin, Venkatesan, K. , Hunter, Craig, Gallegos, Maxx , Foreman, Jordan , Pariser, Joseph J. , MacDonald, Susan M. , Warner, Jonathan N. , Martins, Francisco , Warner, Jonathan, Ruel, Nora H. , Nikolavsky, Dmitriy , Kasabwala, Khushabu , Lopez, Damian

Mayo Clinic

International Journal of Urology | February 3, 2022 | Volume: 29 | Issue: 5 | Pages: 376-382

10.1111/iju.14786 | PMID 35118726 Get It

Objectives Penile urethral stricture disease not associated with hypospadias is rare, and there is a wide range of commonly used surgical repair techniques for this disease. We sought to compile a multi‐institutional database of patients who had surgical correction of strictures in the penile urethra not limited to the meatus, and who had no history of hypospadias, for analysis using the Trauma and Urologic Reconstructive Network of Surgeons length, urethral segment and etiology classification system. Methods A retrospective database from 13 institutions was compiled of patients who had undergone surgical correction of Trauma and Urologic Reconstructive Network of Surgeons length, urethral segment and etiology urethral stricture segments S2b/S2c and excluding E5, with a minimum follow‐up time of 4 months. Failure was defined as cystoscopically confirmed recurrence of a stricture measuring less than 16‐Fr. Results We analyzed 222 patients with a median age of 57 years and a follow‐up of 49 months. The overall surgical success rate was 80.2%. On multivariate analysis, the two variables identified that were predictive of surgical success were stricture length ≤2 cm as well as use of a buccal mucosa graft as compared to use of a fasciocutaneous flap, which had success rates of 83% and 52%, respectively ( P = 0.0004). No statistically significant differences were found based on incisional approach or surgical technique, nor were outcomes different based on etiology or preoperative patient demographics. Conclusions Surgical repair of penile urethral strictures of non‐hypospadiac origin have a favorable overall success rate, at 80.2%. Regardless of incisional approach or surgical technique, all operations appear to have similar outcomes other than repairs using fasciocutaneous flap, which were statistically less successful than those using buccal mucosa graft.
Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration
Kantarci, Kejal , Nedelská, Zuzana , Chen, Qin , Gunter, Jeffrey L. , Przybelski, Scott A. , Lesnick, Timothy G. , Kremers, Walter K. , Fields, Julie A. , Graff‐Radford, Jonathan , Savica, Rodolfo , Lowe, Val J. , Graff‐Radford, Neill R. , Murray, Melissa M., Reichard, R. Ross , Jack, Clifford R. , Petersen, Ronald C. , Ferman, Tanis J. , Graff-Radford, Jonathan , Botha, Hugo , Dickson, Dennis W , Jack, Clifford R , Boeve, Brad , Nedelska, Zuzana , Kantarci, Kejal , Ferman, Tanis J , Kremers, Walter K , Senjem, Matthew L. , Schwarz, Christopher G. , Jones, David T. , Botha, Hugo , Knopman, David S. , Dickson, Dennis W. , Boeve, Bradley F.

Mayo Clinic

Brain Communications | February 3, 2022 | Volume: 4 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcac013 | PMID 35415608 Get It

Abstract Mild cognitive impairment with the core clinical features of dementia with Lewy bodies is recognized as a prodromal stage of dementia with Lewy bodies. Although grey matter atrophy has been demonstrated in prodromal dementia with Lewy bodies, longitudinal rates of atrophy during progression to probable dementia with Lewy bodies are unknown. We investigated the regional patterns of cross-sectional and longitudinal rates of grey matter atrophy in prodromal dementia with Lewy bodies, including those who progressed to probable dementia with Lewy bodies. Patients with mild cognitive impairment with at least one core clinical feature of dementia with Lewy bodies (mean age = 70.5; 95% male), who were enrolled in the Mayo Clinic Alzheimer’s Disease Research Center and followed for at least two clinical evaluations and MRI examinations, were included (n = 56). A cognitively unimpaired control group (n = 112) was matched 2:1 to the patients with mild cognitive impairment by age and sex. Patients either remained stable (n = 28) or progressed to probable dementia with Lewy bodies (n = 28) during a similar follow-up period and pathologic confirmation was available in a subset of cases (n = 18). Cross-sectional and longitudinal rates of grey matter atrophy were assessed using voxel-based and atlas-based region of interest analyses. At baseline, prodromal dementia with Lewy bodies was characterized by atrophy in the nucleus basalis of Meynert both in those who remained stable and those who progressed to probable dementia with Lewy bodies (P &lt; 0.05 false discovery rate corrected). Increase in longitudinal grey matter atrophy rates were widespread, with greatest rates of atrophy observed in the enthorhinal and parahippocampal cortices, temporoparietal association cortices, thalamus and the basal ganglia, in mild cognitive impairment patients who progressed to probable dementia with Lewy bodies at follow-up (P &lt; 0.05 false discovery rate corrected). Rates of inferior temporal atrophy were associated with greater rates of worsening on the clinical dementia rating–sum of boxes. Seventeen of the 18 (94%) autopsied cases had Lewy body disease. Results show that atrophy in the nucleus basalis of Meynert is a feature of prodromal dementia with Lewy bodies regardless of proximity to progression to probable dementia with Lewy bodies. Longitudinally, grey matter atrophy progresses in regions with significant cholinergic innervation, in alignment with clinical disease progression, with widespread and accelerated rates of atrophy in patients who progress to probable dementia with Lewy bodies. Given the prominent neurodegeneration in the cholinergic system, patients with prodromal dementia with Lewy bodies may be candidates for cholinesterase inhibitor treatment.
Abstract 154: Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke
Leeuw, Frank‐Erik de , Cadenas, Israel Fernández, Słowik, Agnieszka, Conde, Jordi Jiménez, Schmidt, Reinhold, Sharma, Pankaj , Rothwell, Peter M. , Sudlow, Catherine, Debette, Stéphanie , Markus, Hugh S. , Saleheen, Danish , Danesh, John , Zand, Ramin , Worrall, Bradford B. , Woo, Daniel , Lee, Jin-moo, Irvin, Marguerite R. , Rosand, Jonathan, Kamatani, Yoichiro, Xu, Huichun , Kittner, Steven J. , Debette, Stephanie , Zand, Ramin , Tomppo, Liisa , Rannikmäe, Kristiina , Stanne, Tara M. , Putaala, Jukka , Strbian, Daniel , Jern, Christina , Boncoraglio, Giorgio B. , Lindgren, Arne G. , Lemmens, Robin , Melander, Olle , Levi, Christopher , Sudlow, Catherine, Metso, Tiina M. , Paré, Guillaume , Meschia, James F. , Rundek, Tatjana , Lee, Jin‐Moo , McDonough, Caitrin W. , Rexrode, Kathryn M. , Wassertheil-Smoller, Sylvia W , Rosand, Jonathan M. , Gieger, Christian , Müller‐Nurasyid, Martina , Salomaa, Veikko , Kamatani, Yoichiro, Walters, Robin G. , Chen, Zhengming , Dichgans, Martin , Malik, Rainer , Gaynor, Brady J. , Cole, John W. , Mitchell, Braxton D.

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.154 Get It

Introduction: Genetic studies of early-onset disease have been an effective strategy to identify novel pathways and drug targets generalizable also to later-onset disease. Few studies have investigated the sex-specific genetic associations with early-onset ischemic stroke even though several features of ischemic stroke differ between males and females. We hypothesized that stratifying the GWAS by sex would reveal novel stroke loci. Methods: We performed a transethnic ischemic stroke GWAS of 3,056 female cases and 4,462 male cases < 60 years-old and 16,192 and 16,048 sex-matched controls, respectively, from the Early Onset Stroke Genetics Consortium. Results: We identified a significant association in women with a locus in close proximity to TMX1 , a transmembrane platelet protein that inhibits platelet function. Additionally, we identified 2 other suggestive (P < 5 x 10 -6 ) loci in females (see Table), i.e., at APOH , which encodes beta2-glycoprotein I, an established GWAS locus for lipoprotein(a), and LRFN2 which has been previously reported to associate with obesity-related measures and type II diabetes. We observed suggestive evidence for association in males with MMP3/MMP12 , a known stroke susceptibility locus. Conclusions: Despite a very modest sample size, sex-specific analyses identified suggestive associations at biologically important novel loci in females and a known stroke locus in males. Further studies of sex-specific associations in both early- and later-onset ischemic stroke are needed.